Skip to main content
. Author manuscript; available in PMC: 2013 Feb 25.
Published in final edited form as: J Pharm Sci. 2011 May 26;100(9):3831–3842. doi: 10.1002/jps.22640

Figure 3.

Figure 3

Figure 3

Figure 3

Uptake of (a) propranolol 10μM, (b) losartan 10μM, and (c) eprosartan 10μM in rat hepatocytes in the presence of uremic toxins or uptake transporter inhibitors. Average ± SD *p<0.05, n=4.